KYOWA HAKKO KIRIN CO LTD |
End-of-day quote
Other stock markets
|
||
| - EUR | - |
|
| 07/05 | Kyowa Kirin's Profit Up 15% in Q1 | MT |
| 06/05 | Kyowa Kirin Buys Back Shares for 5.6 Billion Yen in April | MT |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 474B 3.05B 2.81B 254B | Sales 2025 * | 485B 3.12B 2.88B 261B | Capitalization | 1,414B 9.1B 8.38B 759B |
|---|---|---|---|---|---|
| Net income 2024 * | 66.8B 430M 396M 35.85B | Net income 2025 * | 72.63B 467M 430M 38.98B | EV / Sales 2024 * | 2.29 x |
| Net cash position 2024 * | 328B 2.11B 1.94B 176B | Net cash position 2025 * | 360B 2.32B 2.13B 193B | EV / Sales 2025 * | 2.17 x |
| P/E ratio 2024 * |
21
x | P/E ratio 2025 * |
19.2
x | Employees | - |
| Yield 2024 * |
2.21% | Yield 2025 * |
2.31% | Free-Float | 45.89% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
More news
| Managers | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | - | 01/86/01 | |
Masashi Miyamoto
PSD | President | 64 | 01/85/01 |
| Chief Tech/Sci/R&D Officer | 62 | 01/10/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Takashi Oyamada
BRD | Director/Board Member | 68 | 01/21/01 |
Yoshihisa Suzuki
BRD | Director/Board Member | 68 | 01/22/01 |
| Director/Board Member | 66 | 01/08/01 |
Kyowa Kirin Co., Ltd. specializes in the development, manufacturing and marketing of pharmaceutical and biochemical products. Net sales break down by source of revenue as follows:
- sales of pharmaceutical products (92.6%): prescription products for anemia, cancers, immune and nephrology diseases treatment;
- sales of licenses (7.4%).
At the end of 2021, the group had 3 production sites located in Japan (2) and China.
Net sales break down geographically as follows: Japan (60.9%), Asia (9%), Americas (16.3%) and Europe (13.8%).
Sector
Pharmaceuticals
Calendar
27/06/2024
- Ex-dividend day for interim dividend
Related indices
| 1st Jan change | Capi. | |
|---|---|---|
| -12.85% | 5.06B | |
| +54.35% | 4.85B | |
| +1.60% | 3.85B | |
| +13.34% | 2.37B | |
| -20.85% | 2.36B | |
| +24.62% | 2.27B | |
| -29.25% | 2.22B | |
| -0.50% | 1.64B | |
| -0.93% | 1.58B |
